Henan Kelun Pharmaceutical Co., Ltd.
-
Founded in:
2009-05-22 -
Country:
China -
Address:
North Section of Gongzong 3rd Street, Industrial Cluster Zone, Tangyin County, Anyang City, Henan Province -
Tax NO.:
91410523689717107T -
Registered Funds:
200 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ligustrazine Hydrochloride |
It can dilate the coronary arteries, lower blood pressure, improve myocardial tolerance to hypoxia, inhibit platelet aggregation, excite the respiratory center, relax bronchial smooth muscles, improve ventilation function, prevent the formation of immune complexes, inhibit the growth of pathogens, promote inflammation absorption, enhance capillary density, reduce blood viscosity, improve microcirculation, increase blood supply to important internal organs, and resist thrombosis and dissolve blood clots.
More
It can dilate the coronary arteries, lower blood pressure, improve myocardial tolerance to hypoxia, inhibit platelet aggregation, excite the respiratory center, relax bronchial smooth muscles, improve ventilation function, prevent the formation of immune complexes, inhibit the growth of pathogens, promote inflammation absorption, enhance capillary density, reduce blood viscosity, improve microcirculation, increase blood supply to important internal organs, and resist thrombosis and dissolve blood clots. |
40mg | 76494-51-4 | 12 |
| Sodium chloride |
Ligustrazine is an alkaloid extracted from the traditional Chinese medicine Ligustrazine, and its chemical structure is tetra-pyrazine. Modern pharmacological studies have shown that Ligustrazine has the effects of expanding the coronary artery, lowering blood pressure, improving myocardial hypoxia tolerance, inhibiting platelet aggregation, exciting the respiratory center, relaxing bronchial smooth muscle, improving high ventilation function, preventing the formation of immune complexes, inhibiting the growth of pathogens, promoting inflammatory absorption, enhancing capillary density, reducing blood viscosity, improving blood circulation, and increasing the supply of visceral important organs. This product has anti-platelet aggregation and has a depolymerization effect on aggregated and platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thereby producing anti-thrombotic and thrombolytic effects.
More
Ligustrazine is an alkaloid extracted from the traditional Chinese medicine Ligustrazine, and its chemical structure is tetra-pyrazine. Modern pharmacological studies have shown that Ligustrazine has the effects of expanding the coronary artery, lowering blood pressure, improving myocardial hypoxia tolerance, inhibiting platelet aggregation, exciting the respiratory center, relaxing bronchial smooth muscle, improving high ventilation function, preventing the formation of immune complexes, inhibiting the growth of pathogens, promoting inflammatory absorption, enhancing capillary density, reducing blood viscosity, improving blood circulation, and increasing the supply of visceral important organs. This product has anti-platelet aggregation and has a depolymerization effect on aggregated and platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thereby producing anti-thrombotic and thrombolytic effects. |
0.9g | 7647-14-5 | 43 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ligustrazine Hydrochloride |
It can dilate the coronary arteries, lower blood pressure, improve myocardial tolerance to hypoxia, inhibit platelet aggregation, excite the respiratory center, relax bronchial smooth muscles, improve ventilation function, prevent the formation of immune complexes, inhibit the growth of pathogens, promote inflammation absorption, enhance capillary density, reduce blood viscosity, improve microcirculation, increase blood supply to important internal organs, resist platelet aggregation, disaggregate aggregated platelets, dilate arterioles, improve microcirculation and increase cerebral blood flow, and produce anti-thrombotic and thrombolytic effects.
More
It can dilate the coronary arteries, lower blood pressure, improve myocardial tolerance to hypoxia, inhibit platelet aggregation, excite the respiratory center, relax bronchial smooth muscles, improve ventilation function, prevent the formation of immune complexes, inhibit the growth of pathogens, promote inflammation absorption, enhance capillary density, reduce blood viscosity, improve microcirculation, increase blood supply to important internal organs, resist platelet aggregation, disaggregate aggregated platelets, dilate arterioles, improve microcirculation and increase cerebral blood flow, and produce anti-thrombotic and thrombolytic effects. |
80mg | 76494-51-4 | 12 |
| Sodium chloride |
Ligustrazine is an alkaloid extracted from the traditional Chinese medicine Ligustrazine, and its chemical structure is tetra-pyrazine. Modern pharmacological studies have shown that Ligustrazine has the effects of expanding the coronary artery, lowering blood pressure, improving myocardial hypoxia tolerance, inhibiting platelet aggregation, exciting the respiratory center, relaxing bronchial smooth muscle, improving high ventilation function, preventing the formation of immune complexes, inhibiting the growth of pathogens, promoting inflammatory absorption, enhancing capillary density, reducing blood viscosity, improving blood circulation, and increasing the supply of visceral important organs. This product has anti-platelet aggregation and has a depolymerization effect on aggregated and platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thereby producing anti-thrombotic and thrombolytic effects.
More
Ligustrazine is an alkaloid extracted from the traditional Chinese medicine Ligustrazine, and its chemical structure is tetra-pyrazine. Modern pharmacological studies have shown that Ligustrazine has the effects of expanding the coronary artery, lowering blood pressure, improving myocardial hypoxia tolerance, inhibiting platelet aggregation, exciting the respiratory center, relaxing bronchial smooth muscle, improving high ventilation function, preventing the formation of immune complexes, inhibiting the growth of pathogens, promoting inflammatory absorption, enhancing capillary density, reducing blood viscosity, improving blood circulation, and increasing the supply of visceral important organs. This product has anti-platelet aggregation and has a depolymerization effect on aggregated and platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thereby producing anti-thrombotic and thrombolytic effects. |
0.9g | 7647-14-5 | 43 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Midecamycin A1 |
The antibacterial property is similar to that of erythromycin. It has a strong antibacterial effect on Gram-positive bacteria, and is effective against Staphylococcus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Diphtheria bacillus, Tetanus bacillus, and anthrax bacillus. It also has antibacterial effects on Gram-negative bacteria such as gonococci and pertussis bacillus. It is also effective against Leptospira, Rickettsia, and Mycoplasma. It can be used as a substitute for erythromycin for infections of the oropharynx, respiratory tract, skin and soft tissue, and bile duct caused by the above-mentioned sensitive bacteria.
More
The antibacterial property is similar to that of erythromycin. It has a strong antibacterial effect on Gram-positive bacteria, and is effective against Staphylococcus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Diphtheria bacillus, Tetanus bacillus, and anthrax bacillus. It also has antibacterial effects on Gram-negative bacteria such as gonococci and pertussis bacillus. It is also effective against Leptospira, Rickettsia, and Mycoplasma. It can be used as a substitute for erythromycin for infections of the oropharynx, respiratory tract, skin and soft tissue, and bile duct caused by the above-mentioned sensitive bacteria. |
0 | ||
| Sineptina A6 |
The antibacterial property is similar to that of erythromycin. It has a strong antibacterial effect on Gram-positive bacteria, and is effective against Staphylococcus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Diphtheria bacillus, Tetanus bacillus, and anthrax bacillus. It also has antibacterial effects on Gram-negative bacteria such as gonococci and pertussis bacillus. It is also effective against Leptospira, Rickettsia, and Mycoplasma. It can be used as a substitute for erythromycin for infections of the oropharynx, respiratory tract, skin and soft tissue, and bile duct caused by the above-mentioned sensitive bacteria.
More
The antibacterial property is similar to that of erythromycin. It has a strong antibacterial effect on Gram-positive bacteria, and is effective against Staphylococcus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Diphtheria bacillus, Tetanus bacillus, and anthrax bacillus. It also has antibacterial effects on Gram-negative bacteria such as gonococci and pertussis bacillus. It is also effective against Leptospira, Rickettsia, and Mycoplasma. It can be used as a substitute for erythromycin for infections of the oropharynx, respiratory tract, skin and soft tissue, and bile duct caused by the above-mentioned sensitive bacteria. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Proglumide |
This product is a gastrin receptor antagonist, which can significantly inhibit the secretion of gastric acid and pepsin caused by gastrin, increase the content of hexosamine in gastric mucosa, promote glycoprotein synthesis, and protect and promote the healing of gastric mucosa. It has a choleretic effect, and can prevent stone formation and promote bile duct health by stimulating bile acid-independent bile secretion, changing the stone-forming factors in bile, and antagonizing CCK.
More
This product is a gastrin receptor antagonist, which can significantly inhibit the secretion of gastric acid and pepsin caused by gastrin, increase the content of hexosamine in gastric mucosa, promote glycoprotein synthesis, and protect and promote the healing of gastric mucosa. It has a choleretic effect, and can prevent stone formation and promote bile duct health by stimulating bile acid-independent bile secretion, changing the stone-forming factors in bile, and antagonizing CCK. |
6620-60-6 | 7 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dexamethasone sodium phosphate |
Adrenal cortex hormone drugs. It has anti-inflammatory, anti-allergic, anti-rheumatic and immunosuppressive effects. Its mechanism of action includes: 1. Anti-inflammatory effect: reduce and prevent tissue response to inflammation, inhibit inflammatory cell aggregation and the synthesis and release of inflammatory chemical mediators; 2. Immunosuppressive effect: prevent or inhibit cell-mediated immune response, reduce the number of T lymphocytes, monocytes, eosinophils, reduce the binding ability of immunoglobulins to cell surface receptors, and inhibit the synthesis and release of interleukins, thereby reducing the transformation of T lymphocytes into lymphoblasts.
More
Adrenal cortex hormone drugs. It has anti-inflammatory, anti-allergic, anti-rheumatic and immunosuppressive effects. Its mechanism of action includes: 1. Anti-inflammatory effect: reduce and prevent tissue response to inflammation, inhibit inflammatory cell aggregation and the synthesis and release of inflammatory chemical mediators; 2. Immunosuppressive effect: prevent or inhibit cell-mediated immune response, reduce the number of T lymphocytes, monocytes, eosinophils, reduce the binding ability of immunoglobulins to cell surface receptors, and inhibit the synthesis and release of interleukins, thereby reducing the transformation of T lymphocytes into lymphoblasts. |
55203-24-2 | 25 |